Dimensional Fund Advisors LP Buys Shares of 2,606,620 Accendra Health, Inc. $ACH

Key Points

• Dimensional Fund Advisors acquired 2,606,620 Accendra Health shares worth approximately $5.94 million, representing a 3.41% stake. Several other institutional investors also initiated positions during the first quarter.
• Accendra Health shares opened at $1.24, near their 52-week low of $1.20 and well below the 50-day moving average of $3.13.
• The company reported a quarterly loss of $0.19 per share, missing estimates by $0.06, while analysts maintain a generally cautious outlook with an average “Reduce” rating and a $2.50 price target.

Dimensional Fund Advisors LP purchased a new stake in shares of Accendra Health, Inc. (NYSE:ACH - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,606,620 shares of the company's stock, valued at approximately $5,943,000. Dimensional Fund Advisors LP owned 3.41% of Accendra Health at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Keybank National Association OH bought a new position in Accendra Health in the first quarter valued at about $46,000. Strs Ohio bought a new stake in shares of Accendra Health during the 1st quarter valued at about $413,000. Abel Hall LLC bought a new stake in shares of Accendra Health during the 1st quarter valued at about $44,000. Hsbc Holdings PLC bought a new stake in shares of Accendra Health during the 1st quarter valued at about $34,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Accendra Health during the 1st quarter valued at about $592,000.

Accendra Health Price Performance

Shares of NYSE:ACH opened at $1.24 on Wednesday. Accendra Health, Inc. has a 1-year low of $1.20 and a 1-year high of $5.85. The stock has a market capitalization of $94.96 million, a P/E ratio of -0.32, a P/E/G ratio of 2.16 and a beta of 1.58. The firm's 50 day moving average price is $3.13.

Accendra Health (NYSE:ACH - Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by ($0.06). The firm had revenue of $613.23 million during the quarter. Accendra Health had a negative return on equity of 4.24% and a negative net margin of 11.41%. As a group, research analysts expect that Accendra Health, Inc. will post 0.31 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Zacks Research upgraded shares of Accendra Health from a "strong sell" rating to a "hold" rating in a research note on Tuesday, April 21st. UBS Group boosted their target price on shares of Accendra Health from $3.00 to $4.50 and gave the company a "neutral" rating in a research report on Tuesday, May 12th. Weiss Ratings cut shares of Accendra Health from a "sell (d-)" rating to a "sell (e+)" rating in a report on Thursday, August 6th. Robert W. Baird set a $1.50 price target on shares of Accendra Health and gave the stock a "neutral" rating in a research report on Tuesday. Finally, Citigroup downgraded shares of Accendra Health from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $4.50 to $1.50 in a research report on Monday. Four research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Reduce" and an average target price of $2.50.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.

Want to see what other hedge funds are holding ACH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accendra Health, Inc. (NYSE:ACH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source